Tag Archives: asthma

Three-in-one inhaler cuts asthma attack risk: study

Patients at risk of severe asthma attacks due to asthma that is not controlled with standard treatment could benefit from a single three-in-one inhaler, say the authors of two new studies. Two phase three randomised controlled trials with more than 2,500 patients across 17 countries, presented at the European Respiratory …

Read More »

Asthma treatment option for PBS reimbursement

Since August 1, new once-daily asthma treatment option Arnuity Ellipta is being reimbursed on the PBS, according to GSK Australia. The listing provides “affordable access to another treatment option for suitable asthma patients aged 12 years and over”. “This new once-daily inhaler adds to the treatment options available to patients, …

Read More »

ECP aid effort in asthma-hit state

The Pharmaceutical Society of Australia’s Early Career Pharmacist (ECP) Working Group Tasmanian branch is working to raise the profile of asthma and improve the accurate use of asthma inhalers. The group, along with an Asthma Australia representative, will be conducting asthma inhaler technique assessments in Hobart’s Elizabeth Street Mall on …

Read More »

Food additive’s damaging effect

University of Sydney research shows that nanoparticles, present in many food items, may have a substantial and harmful influence on human health. With research revealing titanium dioxide nanoparticles (E171) can impact the gut microbiota, potentially leading to inflammatory bowel diseases or colorectal cancer, experts are calling for better regulation of …

Read More »

HCF: Catalyst participants revealed

The not-for-profit health fund HCF has announced the nine promising health technology entrepreneurs who will participate in their 2019 Catalyst Accelerator program. The program, now in its fourth year, is designed to support innovation in health care by providing funding and hands-on resources to some of Australia’s most promising new …

Read More »

Networking on asthma/allergies

The National Asthma Council Australia has launched the Health Professionals Network, a community of health professionals who care for people with asthma or allergies, and who want to help improve asthma resources and services. The HPN will be consulted for ideas, feedback and advice to ensure diverse health professional perspectives …

Read More »

Pharmaxis gets FDA approval

Pharmaceutical research company Pharmaxis has received FDA approval to produce the asthma product Aridol for the US market. The approval follows a recent onsite FDA inspection of the Pharmaxis manufacturing facility in Sydney, where the company currently manufactures Aridol for Europe, Australia and South Korea, as well as Bronchitol for …

Read More »

Montelukast safety review

The TGA is undertaking additional risk-mitigation activities following a new safety review of  asthma medication montelukast. The government had requested the TGA conduct a safety review of the drug following reports in the media of serious neuropsychiatric events occurring in association with montelukast in children and adolescents. The review evaluated …

Read More »